Medpace Holdings Files 8-K on Financials and Operations

TL;DR

Medpace dropped an 8-K on Feb 6th covering financials & ops. Check it out.

AI Summary

On February 6, 2025, Medpace Holdings, Inc. filed an 8-K report detailing results of operations and financial condition, along with other events and financial statements. The filing was made on February 10, 2025, and pertains to the company's operations as of February 6, 2025.

Why It Matters

This 8-K filing provides investors with crucial updates on Medpace Holdings, Inc.'s financial performance and operational events, impacting their investment decisions.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for reporting financial results and other events, not indicating any immediate or significant new risks.

Key Players & Entities

• Medpace Holdings, Inc. (company) — Registrant
• February 6, 2025 (date) — Earliest event reported
• February 10, 2025 (date) — Filing date
• 5375 Medpace Way (address) — Principal Executive Offices
• Cincinnati, Ohio (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.01 — hange on which registered Common Stock $0.01 par value MEDP NASDAQ Global Select Mar
• $600 million — (the "Company") approved an increase of $600 million to the Company's stock repurchase progr

Filing Documents

• medp-20250206.htm (8-K) — 27KB
• medp-20250210exx991.htm (EX-99.1) — 176KB
• medpace-logoxonxwhitea.jpg (GRAPHIC) — 10KB
• 0001668397-25-000012.txt ( ) — 355KB
• medp-20250206.xsd (EX-101.SCH) — 2KB
• medp-20250206_lab.xml (EX-101.LAB) — 21KB
• medp-20250206_pre.xml (EX-101.PRE) — 12KB
• medp-20250206_htm.xml (XML) — 3KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On February 10, 2025, Medpace Holdings, Inc. (the "Company") issued a press release announcing its financial results for the three and twelve months ended December 31, 2024. The full text of the press release was posted on the Company's internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.

01 Other Events

Item 8.01 Other Events. On February 6, 2025, the Board of Directors ("Board") of Medpace Holdings, Inc., a Delaware corporation (the "Company") approved an increase of $600 million to the Company's stock repurchase program. The timing, price and volume of repurchases will be based on market conditions, relevant securities laws and other factors. The stock repurchases may be made from time to time, through solicited or unsolicited transactions in the open market, in privately negotiated transactions or pursuant to a Rule 10b5-1 plan. The program may be discontinued or amended at any time without notice.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated February 1 0 , 202 5 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MEDPACE HOLDINGS, INC. Date: February 10, 2025 By: /s/ Kevin M. Brady Kevin M. Brady, Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR